Adrenal activity during repeated long-access cocaine self-administration is required for later CRF-induced and CRF-dependent stressor-induced reinstatement in rats

Neuropsychopharmacology

Volumn 36, Issue 7, 2011, Pages 1444-1454

  Graf, Evan N ^a   Hoks, Michael A ^a   Baumgardner, Jean ^a   Sierra, Jose ^a   Vranjkovic, Oliver ^a   Bohr, Colin ^a   Baker, David A ^a   Mantsch, John R ^a  

^a MARQUETTE UNIVERSITY   (United States)

Author keywords

cocaine; CRF; CRH; elapse; glucocorticoid; stress

Indexed keywords

COCAINE; CORTICOSTERONE; CORTICOTROPIN RELEASING FACTOR; CORTICOTROPIN RELEASING FACTOR[9-41]; NEUROPEPTIDE;

ADRENAL GLAND; ADRENALECTOMY; ANIMAL EXPERIMENT; ARTICLE; CONTROLLED STUDY; DRUG SEEKING BEHAVIOR; DRUG SELF ADMINISTRATION; FOOTSHOCK; INTRACEREBROVENTRICULAR DRUG ADMINISTRATION; MALE; NONHUMAN; PRIORITY JOURNAL; RAT; STRESS;

ADRENALECTOMY; ANALYSIS OF VARIANCE; ANIMALS; BEHAVIOR, ANIMAL; COCAINE; CONDITIONING, OPERANT; CORTICOSTERONE; CORTICOTROPIN-RELEASING HORMONE; DOPAMINE UPTAKE INHIBITORS; EXTINCTION, PSYCHOLOGICAL; MALE; PEPTIDE FRAGMENTS; RATS; RATS, SPRAGUE-DAWLEY; REINFORCEMENT (PSYCHOLOGY); REINFORCEMENT SCHEDULE; SELF ADMINISTRATION;

EID: 79956020911     PISSN: 0893133X     EISSN: 1740634X     Source Type: Journal    
DOI: 10.1038/npp.2011.28     Document Type: Article

References (86)

1. Ahmed SH, Koob GF (1997). Cocaine- but not food-seeking behavior is reinstated by stress after extinction. Psycho-pharmacology 132: 289-295. (Pubitemid 27351430)
2. Ahmed SH, Koob GF (1998). Transition from moderate to excessive drug intake: change in hedonic set point. Science 282: 298-300. (Pubitemid 28487203)
3. Ambroggi F, Turiault M, Milet A, Deroche-Gamonet V, Parnau-deau S, Balado E et al (2009). Stress and addiction: glucocorti-coid receptor in dopaminoceptive neurons facilitates cocaine seeking. Nat Neurosci 12: 247-249.
4. Berger SP, Hall S, Mickalian JD, Reid MS, Crawford CA, Delucchi K et al (1996). Haloperidol antagonism of cue-elicited cocaine craving. Lancet 347: 504-508. (Pubitemid 26061611)
5. Broadbear JH, Winger G, Cicero TJ, Woods JH (1999a). Effects of self-administered cocaine on plasma adrenocorticotropic hormone and cortisol in male rhesus monkeys. J Pharmacol Exp Ther 289: 1641-1647. (Pubitemid 29246701)
6. Broadbear JH, Winger G, Woods JH (1999b). Cocaine-reinforced responding in rhesus monkeys: pharmacological attenuation of the hypothalamic-pituitary- adrenal axis response. J Pharmacol Exp Ther 290: 1347-1355. (Pubitemid 29400279)
7. Bruijnzeel AW, Prado M, Isaac S (2009). Corticotropin-releasing factor-1 receptor activation mediates nicotine withdrawal-induced deficit in brain reward function and stress-induced relapse. Biol Psychiatry 66: 110-117.
8. Campbell UC, Carroll ME (2001). Effects of ketoconazole on the acquisition of intravenous cocaine self-administration under different feeding conditions in rats. Psychopharmacology 154: 311-318. (Pubitemid 32247192)
9. Chen A, Perrin M, Brar B, Li C, Jamieson P, Digruccio M et al (2005). Mouse corticotropin-releasing factor receptor type 2alpha gene: isolation, distribution, pharmacological characterization and regulation by stress and glucocorticoids. Mol Endocrinol 19: 441-458. (Pubitemid 40223468)
10. De Jong IE, Oitzl MS, de Kloet ER (2007). Adrenalectomy prevents behavioural sensitisation of mice to cocaine in a genotype-dependent manner. Behav Brain Res 177: 329-339. (Pubitemid 46149901)
11. De Jong IE, Steenbergen PJ, de Kloet ER (2009). Behavioral sensitization to cocaine: cooperation between glucocorticoids and epinephrine. Psychopharmacology 204: 693-703.
12. De Kloet ER, de Jong IE, Oitzl MS (2008). Neuropharmacology of glucocorticoids: focus on emotion, cognition and cocaine. Eur J Pharmacol 585: 473-482.
13. Deroche V, Marinelli M, Le Moal M, Piazza PV (1997). Glucocorticoids and behavioral effects of psychostimulants. II. Cocaine intravenous self-administration and reinstatement depend on glucocorticoid levels. J Pharmacol Exp Ther 281: 1401-1407. (Pubitemid 27258400)
14. Deroche-Gamonet V, Sillaber I, Aouizerate B, Izawa R, Jaber M, Ghozland S et al (2003). The glucocorticoid receptor as a potential target to reduce cocaine abuse. J Neurosci 23: 4785-4790. (Pubitemid 36706207)
15. Erb S, Funk D, Le AD (2003). Prior, repeated exposure to cocaine potentiates locomotor responsivity to central injections of corticotropin- releasing factor (CRF) in rats. Psycho-pharmacology 170: 383-389. (Pubitemid 38010510)
16. Erb S, Funk D, Lê AD (2005). Cocaine pre-exposure enhances CRF-induced expression of c-fos mRNA in the central nucleus of the amygdala: an effect that parallels the effects of cocaine pre-exposure on CRF-induced locomotor activity. Neurosci Lett 383: 209-214. (Pubitemid 40805557)
17. Erb S, Petrovic A, Yi D, Kayyali H (2006). Central injections of CRF reinstate cocaine seeking in rats after postinjection delays of up to 3 h: an influence of time and environmental context. Psychopharmacology 187: 112-120. (Pubitemid 43876923)
18. Erb S, Salmaso N, Rodaros D, Stewart J (2001). A role for the CRF-containing pathway from central nucleus of the amygdala to bed nucleus of the stria terminalis in the stress-induced reinstatement of cocaine seeking in rats. Psychopharmacology 158: 360-365. (Pubitemid 33141311)
19. Erb S, Shaham Y, Stewart J (1996). Stress reinstates cocaine-seeking behavior after prolonged extinction and a drug-free period. Psychopharmacology 128: 408-412. (Pubitemid 26417682)
20. Erb S, Shaham Y, Stewart J (1998). The role of corticotropin-releasing factor and corticosterone in stress- and cocaine-induced relapse to cocaine seeking in rats. J Neurosci 18: 5529-5536. (Pubitemid 28311967)
21. Erb S, Stewart J (1999). A role for the bed nucleus of the stria terminalis, but not the amygdala, in the effects of corticotropin-releasing factor on stress-induced reinstatement of cocaine seeking. J Neurosci 19: RC35.
22. Francesconi W, Berton F, Repunte-Canonigo V, Hagihara K, Thurbon D, Lekic D et al (2009). Protracted withdrawal from alcohol and drugs of abuse impairs long-term potentiation of intrinsic excitability in the juxtacapsular bed nucleus of the stria terminalis. J Neurosci 29: 5389-5401.
23. Galici R, Pechnick RN, Poland RE, France CP (2000). Comparison of noncontingent versus contingent cocaine administration on plasma corticosterone levels in rats. Eur J Pharmacol 387: 59-62. (Pubitemid 30035374)
24. Goeders NE, Bienvenu OJ, De Souza EB (1990). Chronic cocaine administration alters corticotrophin releasing factor receptors in the rat brain. Brain Res 531: 322-328. (Pubitemid 20348642)
25. Goeders NE, Guerin GF (1996). Effects of surgical and pharmacological adrenalectomy on the initiation and maintenance of intravenous cocaine self-administration in rats. Brain Res 25: 145-152. (Pubitemid 26199364)
26. Goeders NE, Guerin GF (2000). Effects of the CRH receptor antagonist CP-154,526 on intravenous cocaine self-administration in rats. Neuropsychopharmacology 23: 577-586.
27. Guan X, Zhang R, Xu Y, Li S (2009). Cocaine withdrawal enhances long-term potentiation in rat hippocampus via changing the activity of corticotropin-releasing factor receptor subtype 2. Neuroscience 161: 665-670.
28. Hahn J, Hopf FW, Bonci A (2009). Chronic cocaine enhances corticotropin-releasing factor-dependent potentiation of excitatory transmission in ventral tegmental area dopamine neurons. J Neurosci 29: 6535-6544.
29. Harfstrand A, Fuxe K, Cintra A, Agnati LF, Zini I, Wikstrom AC et al (1986). Glucocorticoid receptor immunoreactivity in monoaminer-gic neurons of rat brain. Proc Natl Acad Sci USA 83: 9779-9783. (Pubitemid 17223440)
30. Harris DS, Batki SL, Berger SP (2004). Fluoxetine attenuates adrenocortical but not subjective responses to cocaine cues. Am J Drug Alcohol Abuse 30: 765-782. (Pubitemid 39578303)
31. Jacobson L, Akana SF, Cascio CS, Shinsako J, Dallman MF (1988). Circadian variations in plasma corticosterone permit normal termination of the adrenocorticotropin responses to stress. Endocrinology 122: 1343-1348. (Pubitemid 18091962)
32. Kageyama K, Li C, Vale WW (2003). Corticotropin-releasing factor receptor type 2 messenger ribonucleic acid in rat pituitary: localization and regulation by immune challenge, restraint stress, and glucocorticoids. Endocrinology 144: 1524-2532.
33. Koob G, Kreek MJ (2007). Stress, dysregulation of drug reward pathways, and the transition to drug dependence. Am J Psychiatry 164: 1149-1159. (Pubitemid 47292402)
34. Kreek MJ, Koob GF (1998). Drug dependence: stress and dysregulation of brain reward pathways. Drug Alcohol Depend 51: 23-47. (Pubitemid 28353754)
35. Lê AD, Harding S, Juzytsch W, Watchus J, Shalev U, Shaham Y (2000). The role of corticotrophin-releasing factor in stress-induced relapse to alcohol-seeking behavior in rats. Psycho-pharmacology 150: 317-324. (Pubitemid 30447852)
36. Lee B, Tiefenbacher S, Platt DM, Spealman RD (2003). Role of the hypothalamic-pituitary-adrenal axis in reinstatement of cocaine-seeking behavior in squirrel monkeys. Psychopharmacology 168: 177-183. (Pubitemid 36851177)
37. Lee Y, Schulkin J, Davis M (1994). Effect of corticosterone on the enhancement of the acoustic startle reflex by corticotropin releasing factor (CRF). Brain Res 666: 93-98. (Pubitemid 24359656)
38. Liu J, Yu B, Orozco-Cabal L, Grigoriadis DE, Rivier J, Vale WW et al (2005). Chronic cocaine administration switches cortico-tropin-releasing factor2 receptor-mediated depression to facilitation of glutamatergic transmission in the lateral septum. J Neurosci 25: 577-583.
39. Lu L, Liu D, Ceng X (2001). Corticotropin-releasing factor receptor type 1 mediates stress-induced relapse to cocaine-conditioned place preference in rats. Eur J Pharmacol 415: 203-208. (Pubitemid 32239465)
40. Makino S, Gold PW, Schulkin J (1994a). Effects of corticosterone on CRH mRNA and content in the bed nucleus of the stria terminalis; comparison with the effects in the central nucleus of the amygdala and the paraventricular nucleus of the hypotha-lamus. Brain Res 657: 141-149. (Pubitemid 24281258)
41. Makino S, Gold PW, Schulkin J (1994b). Corticosterone effects on corticotropin-releasing hormone mRNA in the central nucleus of the amygdala and the parvocellular region of the paraventricular nucleus of the hypothalamus. Brain Res 640: 105-112. (Pubitemid 24086536)
42. Makino S, Schulkin J, Smith MA, Pacák K, Palkovits M, Gold PW (1995). Regulation of corticotropin-releasing hormone receptor messenger ribonucleic acid in the rat brain and pituitary by glucocorticoids and stress. Endocrinology 136: 4517-4525.
43. Mantsch JR, Baker DA, Francis DM, Katz ES, Hoks MA, Serge JP (2008a). Stressor- and corticotropin releasing factor-induced reinstatement and active stress-related behavioral responses are augmented following long-access cocaine self-administration by rats. Psychopharmacology 195: 591-603. (Pubitemid 350160496)
44. Mantsch JR, Baker DA, Serge JP, Hoks MA, Francis DM, Katz ES (2008b). Surgical adrenalectomy with diurnal corticosterone replacement slows escalation and prevents the augmentation of cocaine-induced reinstatement in rats self-administering cocaine under long-access conditions. Neuropsychopharmacology 33: 814-826. (Pubitemid 351252699)
45. Mantsch JR, Cullinan WE, Tang LC, Baker DA, Katz ES, Hoks MA et al (2007). Daily cocaine self-administration under long-access conditions augments restraint-induced increases in plasma corticosterone and impairs glucocorticoid receptor-mediated negative feedback in rats. Brain Res 1167: 101-111. (Pubitemid 47302439)
46. Mantsch JR, Katz ES (2007). Elevated glucocorticoids are necessary but not sufficient for the escalation of cocaine self-administration by chronic electric footshock stress in rats. Neuropsycho-pharmacology 32: 367-376. (Pubitemid 46106943)
47. Mantsch JR, Saphier D, Goeders NE (1998). Corticosterone facilitates the acquisition of cocaine self-administration in rats: opposite effects of the type II receptor agonist dexamethasone. J Pharmacol Exp Ther 287: 72-80. (Pubitemid 29140188)
48. Mantsch JR, Yuferov V, Mathieu-Kia AM, Ho A, Kreek MJ (2003). Neuroendocrine alterations in a rat high-dose, extended-access self-administration model of escalating cocaine use. Psycho-neuroendocrinology 28: 836-862. (Pubitemid 36936795)
49. Mantsch JR, Yuferov V, Mathieu-Kia AM, Ho A, Kreek MJ (2004). Effects of extended access to high versus low cocaine doses on self-administration, cocaine-induced reinstatement and brain mRNA levels in rats. Psychopharmacology 175: 26-36. (Pubitemid 39215527)
50. Marinelli M, Piazza PV (2002). Interaction between glucocorticoid hormones, stress and psychostimulant drugs. Eur J Neurosci 16: 387-394. (Pubitemid 35471854)
51. Merali Z, Anisman H, James JS, Kent P, Schulkin J (2008). Effects of corticosterone on corticotrophin-releasing hormone and gastrin-releasing peptide release in response to an aversive stimulus in two regions of the forebrain (central nucleus of the amygdala and prefrontal cortex). Eur J Neurosci 28: 165-172.
52. Meyer JS, Micco DJ, Stephenson BS, Krey LC, McEwen BS (1979). Subcutaneous implantation method for chronic glucocorticoid replacement therapy. Physiol Behav 22: 867-870. (Pubitemid 9214715)
53. Morales-Medina JC, Sanchez F, Flores G, Dumont Y, Quirion R (2009). Morphological reorganization after repeated corticoster-one administration in the hippocampus, nucleus accumbens and amygdala in the rat. J Chem Neuroanat 38: 266-272.
54. Orozco-Cabal L, Liu J, Pollandt S, Schmidt K, Shinnick-Gallagher P, Gallagher JP (2008). Dopamine and corticotropin-releasing factor synergistically alter basolateral amygdala-to-medial prefrontal cortex synaptic transmission: functional switch after chronic cocaine administration. J Neurosci 28: 529-542.
55. Paxinos G, Watson C (1998). The Rat Brain in Stereotaxic Coordinates, 4th edition. Academic Press: San Diego.
56. Piazza PV, Le Moal ML (1996). Pathophysiological basis of vulnerability to drug abuse: role of an interaction between stress, glucocorticoids, and dopaminergic neurons. Annu Rev Pharmacol Toxicol 36: 359-378. (Pubitemid 26168703)
57. Pollandt S, Liu J, Orozco-Cabal L, Grigoriadis DE, Vale WW, Gallagher JP et al (2006). Cocaine withdrawal enhances long-term potentiation induced by corticotropin-releasing factor at central amygdala glutamatergic synapses via CRF, NMDA receptors and PKA. Eur J Neurosci 24: 1733-1743. (Pubitemid 44427542)
58. Prasad BM, Ulibarri C, Kalivas PW, Sorg BA (1996). Effect of adrenalectomy on the initiation and expression of cocaine-induced sensitization. Psychopharmacology 125: 265-273. (Pubitemid 26186183)
59. Prasad BM, Ulibarri C, Sorg BA (1998). Stress-induced cross-sensitization to cocaine: effect of adrenalectomy and corticos-terone after short- and long-term withdrawal. Psychopharmacology 136: 24-33. (Pubitemid 28097517)
60. Przegaliński E, Filip M, Frankowska M, Zaniewska M, Papla I (2005). Effects of CP 154,536, a CRF1 receptor antagonist, on behavioral responses to cocaine in rats. Neuropeptides 39: 525-533. (Pubitemid 41443528)
61. Przegaliński E, Filip M, Siwanowicz J, Nowak E (2000). Effect of adrenalectomy and corticosterone on cocaine-induced sensitiza-tion in rats. J Physiol Pharmacol 51: 193-204. (Pubitemid 30436069)
62. Richter RM, Pich EM, Koob GF, Weiss F (1995). Sensitization of cocaine-stimulated increase in extracellular levels of corticotro-pin-releasing factor from the rat amygdala after repeated administration as determined by intracranial microdialysis. Neurosci Lett 187: 169-172.
63. Richter RM, Weiss F (1999). In vivo CRF release in rat amygdala is increased during cocaine withdrawal in self-administering rats. Synapse 32: 254-261. (Pubitemid 29222639)
64. Roozendaal B (2002). Stress and memory: opposing effects of glucocorticoids on memory consolidation and memory retrieval. Neurobiol Learn Mem 78: 578-595. (Pubitemid 36268680)
65. Rouge-Pont F, Marinelli M, Le Moal M, Simon H, Piazza PV (1995). Stress-induced sensitization and glucocorticoids. II. Sensitization of the increase in extracellular dopamine induced by cocaine depends on stress-induced corticosterone secretion. J Neurosci 15: 7189-7195.
66. Sandi C (1998). The role and mechanisms of action of glucocorticoid involvement in memory storage. Neural Plast 6: 41-52. (Pubitemid 29454468)
67. Sarnyai Z, Shaham Y, Heinrichs SC (2001). The role of corticotropin-releasing factor in drug addiction. Pharmacol Rev 53: 209-243. (Pubitemid 32476116)
68. Schulkin J, Gold PW, McEwen BS (1998). Induction of cortico-tropin- releasing hormone gene expression by glucocorticoids: implication for understanding the states of fear and anxiety and allostatic load. Psychoneuroendocrinol 23: 219-243. (Pubitemid 28352490)
69. Shaham Y, Erb S, Leung S, Buczek Y, Stewart J (1998). CP-154,526, a selective, non-peptide antagonist of the corticotropin-releasing factor1 receptor attenuates stress-induced relapse to drug seeking in cocaine- and heroin-trained rats. Psychopharmacology 137: 184-190. (Pubitemid 28227336)
70. Shaham Y, Funk D, Erb S, Brown TJ, Walker CD, Stewart J (1997). Corticotropin-releasing factor, but not corticosterone, is involved in stress-induced relapse to heroin-seeking in rats. J Neurosci 17: 2605-2614. (Pubitemid 27137426)
71. Shalev U, Erb S, Shaham Y (2010). Role of CRF and other neuropeptides in stress-induced reinstatement of drug seeking. Brain Res 1314: 15-28.
72. Shalev U, Finnie PS, Quinn T, Tobin S, Wahi P (2006). A role for corticotropin-releasing factor, but not corticosterone, in acute food-deprivation-induced reinstatement of heroin seeking in rats. Psychopharmacology 187: 376-384. (Pubitemid 44079929)
73. Shepard JD, Barron KW, Myers DA (2000). Corticosterone delivery to the amygdala increases corticotropin-releasing factor mRNA in the central amygdaloid nucleus and anxiety-like behavior. Brain Res 861: 288-295. (Pubitemid 30173314)
74. Shepard JD, Schulkin J, Myers DA (2006). Chronically elevated corticosterone in the amygdala increases corticotropin releasing factor mRNA in the dorsolateral bed nucleus of stria terminalis following duress. Behav Brain Res 174: 193-196. (Pubitemid 44397188)
75. Sinha R, Catapano D, O'Malley S (1999). Stress-induced craving and stress response in cocaine dependent individuals. Psycho-pharmacology 142: 343-351. (Pubitemid 29187622)
76. Sinha R, Fuse T, Aubin LR, O'Malley SS (2000). Psychological stress, drug-related cues and cocaine craving. Psychopharmacol-ogy 152: 140-148.
77. Sinha R, Talih M, Malison R, Cooney N, Anderson GM, Kreek MJ (2003). Hypothalamic-pituitary-adrenal axis and sympatho-adreno-medullary responses during stress-induced and drug cue-induced cocaine craving states. Psychopharmacology 170: 62-72. (Pubitemid 37372479)
78. Specio SE, Wee S, O'Dell LE, Boutrel B, Zorrilla EP, Koob GF (2008). CRF(1) receptor antagonists attenuate escalated cocaine self-administration in rats. Psychopharmacology 196: 473-482. (Pubitemid 351191180)
79. Wang B, Shaham Y, Zitzman D, Azari S, Wise RA, You ZB (2005). Cocaine experience establishes control of midbrain glutamate and dopamine by corticotropin-releasing factor: a role in stress-induced relapse to drug seeking. J Neurosci 25: 5389-5396. (Pubitemid 40770919)
80. Wang B, You ZB, Rice KC, Wise RA (2007). Stress-induced relapse to cocaine seeking: roles for the CRF(2) receptor and CRF-binding protein in the ventral tegmental area of the rat. Psychopharmacology 193: 283-294. (Pubitemid 47025028)
81. Ward AS, Collins ED, Haney M, Foltin RW, Fischman MW (1999). Blockade of cocaine-induced increases in adrenocorticotrophic hormone and cortisol does not attenuate the subjective effects of smoked cocaine in humans. Behav Pharmacol 10: 523-529. (Pubitemid 29440560)
82. Wei Q, Lu XY, Liu L, Schafer G, Shieh KR, Burke S et al (2004). Glucocorticoid receptor overexpression in forebrain: a mouse model of increased emotional lability. Proc Natl Acad Sci USA 101: 11851-11856. (Pubitemid 39095383)
83. Wellman CL (2001). Dendritic reorganization in pyramidal neurons in medial prefrontal cortex after chronic corticosterone administration. J Neurobiol 49: 245-253. (Pubitemid 33000770)
84. Winhusen T, Somoza E, Harrer JM, Moore E, Ussery T, Kropp F et al (2005). Metyrapone and cocaine: a double-blind, placebo-controlled drug interaction study. Pharmacol Biochem Behav 80: 631-638. (Pubitemid 41583212)
85. Zhou Y, Spangler R, Ho A, Kreek MJ (2003). Increased CRH mRNA levels in the rat amygdala during short-term withdrawal from chronic 'binge' cocaine. Brain Res Mol Brain Res 114: 73-79. (Pubitemid 36627998)
86. Zorrilla EP, Valdez GR, Weiss F (2001). Changes in levels of regional CRF-like-immunoreactivity and plasma corticosterone during protracted drug withdrawal in dependent rats. Psycho-pharmacology 158: 374-381. (Pubitemid 33141313)